NFKB1 and tuberculosis: In this study, we have shown NF-κB activity was up-regulated in AM of TB patients and was suppressed by the treatment with ERK or p38 MAPK inhibitors, suggesting ERK and p38 signaling pathways are essential in NF-κB activation in AM of TB patients.